- Home
- ALLO vs FMAO Comparison
ALLO vs FMAO Comparison
Compare ALLO & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- FMAO
- Stock Information
- Founded
- ALLO 2017
- FMAO 1897
- Country
- ALLO United States
- FMAO United States
- Employees
- ALLO N/A
- FMAO N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- FMAO Savings Institutions
- Sector
- ALLO Health Care
- FMAO Finance
- Exchange
- ALLO Nasdaq
- FMAO Nasdaq
- Market Cap
- ALLO 431.9M
- FMAO 377.5M
- IPO Year
- ALLO 2018
- FMAO N/A
- Fundamental
- Price
- ALLO $2.07
- FMAO $31.92
- Analyst Decision
- ALLO Buy
- FMAO Hold
- Analyst Count
- ALLO 12
- FMAO 2
- Target Price
- ALLO $10.06
- FMAO $26.00
- AVG Volume (30 Days)
- ALLO 2.5M
- FMAO 19.3K
- Earning Date
- ALLO 11-07-2024
- FMAO 02-11-2025
- Dividend Yield
- ALLO N/A
- FMAO 2.70%
- EPS Growth
- ALLO N/A
- FMAO N/A
- EPS
- ALLO N/A
- FMAO 1.69
- Revenue
- ALLO $43,000.00
- FMAO $98,003,000.00
- Revenue This Year
- ALLO N/A
- FMAO N/A
- Revenue Next Year
- ALLO N/A
- FMAO $8.16
- P/E Ratio
- ALLO N/A
- FMAO $19.00
- Revenue Growth
- ALLO 26.47
- FMAO N/A
- 52 Week Low
- ALLO $1.83
- FMAO $18.99
- 52 Week High
- ALLO $5.78
- FMAO $34.15
- Technical
- Relative Strength Index (RSI)
- ALLO 41.06
- FMAO 49.79
- Support Level
- ALLO $1.83
- FMAO $31.70
- Resistance Level
- ALLO $2.09
- FMAO $33.02
- Average True Range (ATR)
- ALLO 0.14
- FMAO 0.97
- MACD
- ALLO -0.01
- FMAO -0.26
- Stochastic Oscillator
- ALLO 30.38
- FMAO 10.29
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company for Farmers & Merchants Bank of Central California. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.